| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,052 |
4,244 |
$192K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,632 |
2,305 |
$80K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
294 |
264 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
522 |
465 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
72 |
70 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
227 |
106 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
30 |
29 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$194.46 |
| 90688 |
|
47 |
42 |
$135.09 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
33 |
27 |
$114.87 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
13 |
$86.24 |
| 0031A |
|
14 |
13 |
$85.17 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
126 |
108 |
$69.62 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
13 |
$54.36 |
| 81003 |
|
15 |
13 |
$15.12 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
13 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
63 |
56 |
$0.00 |
| 91303 |
|
14 |
13 |
$0.00 |